DRMAW stock · MSFT stock · Lician Pro · $19.99/mo or $149/yr
DRMAW vs MSFT
Dermata Therapeutics Inc. Warrant (DRMAW) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) warrant listed on NASDAQ.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
DRMAW does not have a complete income-statement cache yet.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. Revenue was up 17.8% from 2025-06-30 to 2026-06-30. MSFT currently screens at market cap $3.71T.
MSFT currently screens at market cap $3.71T.
Not investment advice. Open the DRMAW and MSFT stock pages for the full models.
Basic comparison
Price, market cap, and trailing P/E stay on this page.
| Metric | DRMAW | MSFT |
|---|---|---|
| Price | $0.00 | $529.05 |
| Market cap | — | $3.71T |
| Trailing P/E | — | — |
Deeper peer metrics
Net income and multi-year revenue growth are the peek. More peer metrics open below. This block stops at the labels.
| Metric | DRMAW | MSFT |
|---|---|---|
| Net income | Pro | Pro |
| Revenue growth | Pro | Pro |
More peer metrics
Operating margin, EPS, free cash flow, and gross margin are on Pro.
DRMAW vs MSFT comparison FAQ
What is MSFT's market cap?
Microsoft Corporation (MSFT) currently screens at market cap $3.71T.
What is MSFT's latest revenue?
Latest reported MSFT revenue for 2026-06-30 was $331.84B.
What is MSFT's net income?
Net income was $133.75B for Microsoft Corporation (MSFT).
How did MSFT revenue change on this page?
Revenue was up 17.8% from 2025-06-30 to 2026-06-30.
How many DRMAW vs MSFT comparison scalars are listed on this page?
This page lists 4 cached comparison scalars for DRMAW vs MSFT: MSFT market cap, MSFT revenue, MSFT net income, and MSFT revenue change.
Where is the DRMAW vs MSFT comparison listed?
The cached DRMAW vs MSFT comparison is listed at https://lician.com/compare/drmaw-vs-msft.
Not investment advice.